Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 22 studies | 27% ± 8% | |
| astrocyte | 13 studies | 55% ± 18% | |
| adipocyte | 7 studies | 26% ± 5% | |
| fibroblast | 5 studies | 23% ± 6% | |
| retinal bipolar neuron | 3 studies | 19% ± 1% | |
| rod bipolar cell | 3 studies | 18% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% | |
| endothelial cell | 3 studies | 28% ± 6% |
Insufficient scRNA-seq data for expression of COL5A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 10348.14 | 458 / 459 | 93% | 27.72 | 1044 / 1118 |
| skin | 99% | 6504.42 | 1798 / 1809 | 86% | 35.29 | 408 / 472 |
| esophagus | 96% | 5076.80 | 1388 / 1445 | 87% | 27.09 | 160 / 183 |
| brain | 85% | 5427.68 | 2258 / 2642 | 97% | 31.31 | 685 / 705 |
| intestine | 96% | 4655.78 | 932 / 966 | 73% | 11.35 | 387 / 527 |
| uterus | 100% | 8774.02 | 170 / 170 | 69% | 14.54 | 317 / 459 |
| lung | 97% | 4533.04 | 561 / 578 | 71% | 13.75 | 819 / 1155 |
| bladder | 100% | 3992.90 | 21 / 21 | 66% | 12.39 | 331 / 504 |
| thymus | 96% | 4311.00 | 625 / 653 | 63% | 8.12 | 384 / 605 |
| stomach | 64% | 2375.80 | 230 / 359 | 77% | 14.44 | 220 / 286 |
| liver | 57% | 1844.27 | 129 / 226 | 76% | 22.03 | 309 / 406 |
| prostate | 98% | 5535.87 | 241 / 245 | 24% | 1.97 | 119 / 502 |
| adrenal gland | 62% | 1235.33 | 159 / 258 | 60% | 10.19 | 139 / 230 |
| pancreas | 23% | 407.55 | 76 / 328 | 89% | 18.86 | 158 / 178 |
| ovary | 56% | 1595.04 | 101 / 180 | 44% | 7.90 | 190 / 430 |
| adipose | 100% | 13486.70 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 5216.18 | 845 / 861 | 0% | 0 | 0 / 0 |
| muscle | 85% | 2157.93 | 681 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 24.13 | 38 / 45 |
| kidney | 22% | 596.28 | 20 / 89 | 60% | 12.60 | 540 / 901 |
| blood vessel | 76% | 2510.50 | 1018 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 12.60 | 19 / 29 |
| eye | 0% | 0 | 0 / 0 | 16% | 1.43 | 13 / 80 |
| spleen | 4% | 59.97 | 9 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 6.13 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0043588 | Biological process | skin development |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005588 | Cellular component | collagen type V trimer |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0008201 | Molecular function | heparin binding |
| GO_0043394 | Molecular function | proteoglycan binding |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| GO_0005518 | Molecular function | collagen binding |
| Gene name | COL5A3 |
| Protein name | Collagen alpha-3(V) chain |
| Synonyms | |
| Description | FUNCTION: Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. |
| Accessions | ENST00000264828.4 P25940 |
